Friday, July 10, 2026

pharma · Tuberculosis · Meningococcal Meningitis

CanSino Biologics

CanSino Biologics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Tianjin, CN HQ
2009 Founded
138 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Tianjin, CN
Founded
2009
Employees
138
Programs
3
Drugs
9
Patents
0
Intelligence · Clinical Trials

CanSino Biologics clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to CanSino Biologics programs — each row shows trial ID, program name, phase, status, and indication.

CanSino Biologics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for CanSino Biologics.

  1. CTP-VLP-002 — Phase 2

    Clinical update
  2. Tuberculosis (TB) vaccine (Ad5-105K) — Phase 1

    Clinical update
  3. batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4) — Phase 3

    Clinical update

Trial registry

3 studies